New FDA Programs Cut Down on Big Pharma Calls to CDER Ombudsman

CDER has implemented new outreach programs that last year dramatically reduced the use of the agency’s ombudsman’s office — the main gateway for complaints against the center. In its annual report issued recently, the CDER ombudsman reported it received 282 communications in 2011, down from 1,015 in 2010.
Washington Drug Letter